Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Velsipity“
Suchtreffer
Begriffe & Kennungen
Velsipity
Eintrag öffnenVelsipity · 4.1 Therapeutic indications · 1
Eintrag öffnenVelsipity · 4.3 Contraindications · 1
Eintrag öffnenVelsipity · 4.3 · • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. • Immunodeficien
Eintrag öffnenVelsipity · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenVelsipity · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenVelsipity · 4.5 · 8 Anti-arrhythmic medicinal products, QT prolonging medicinal products, medicinal products that may decrease h
Eintrag öffnenVelsipity · 4.5 · Anti-neoplastic, immune-modulating, or non-corticosteroid immunosuppressive therapies
Eintrag öffnenVelsipity · 4.5 · Beta blockers and calcium channel blockers
Eintrag öffnenVelsipity · 4.5 · Caution is recommended for patients receiving medicinal products that slow heart rate or atrioventricular cond
Eintrag öffnenVelsipity · 4.5 · Class Ia (e.g., quinidine, procainamide) and Class III (e.g., amiodarone, sotalol) anti-arrhythmic medicinal p
Eintrag öffnenVelsipity · 4.5 · Due to the potential additive effects on heart rate, if treatment initiation with etrasimod is considered in p
Eintrag öffnenVelsipity · 4.5 · Due to the potential for increased exposure of etrasimod, co-administration of etrasimod in patients who are k
Eintrag öffnenVelsipity · 4.5 · Effect of CYP2C9 polymorphism
Eintrag öffnenVelsipity · 4.5 · Effect of inducers of CYP2C8, CYP2C9, and CYP3A4 on etrasimod
Eintrag öffnenVelsipity · 4.5 · Effect of inhibitors of CYP2C8, CYP2C9, and CYP3A4 on etrasimod
Eintrag öffnenVelsipity · 4.5 · Etrasimod has not been studied in combination with anti-neoplastic, immune-modulating, or non-corticosteroid i
Eintrag öffnenVelsipity · 4.5 · Etrasimod has not been studied in patients taking QT prolonging medicinal products.
Eintrag öffnenVelsipity · 4.5 · Interaction studies have only been performed in adults.
Eintrag öffnenVelsipity · 4.5 · No clinically significant differences in the pharmacokinetics and pharmacodynamics of an oral contraceptive co
Eintrag öffnen